Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Jan 1997, 217-222, Vol 35, No. 1
DL Stone, MC Moheng, S Rolih and LT Sinor
A solid-phase erythrocyte adherence assay has been developed for the
serological detection of reagin antibodies in syphilis. Capture-S (Immucor,
Inc., Norcross, Ga.) is a nontreponemal, qualitative screening test for the
detection of immunoglobulin G (IgG) and IgM antilipid antibodies in serum
or plasma samples from blood donors. The Capture-S assay utilizes a
modified Venereal Disease Research Laboratory antigen bound to
microtitration wells and anti-IgG- plus anti-IgM-coated indicator
erythrocytes as the detection system. The Capture-S assay was evaluated at
six separate sites on 10,942 specimens. For patient samples of clinically
diagnosed syphilis categories (n = 366), the Capture-S assay yielded a
sensitivity of 80.7% versus 80.3% for the rapid plasma reagin (RPR) card
test (Becton Dickinson Microbiology Systems, Cockeysville, Md.). In
comparative experiments on patient and donor samples (n = 10,222), the
Capture-S assay demonstrated a sensitivity of 94% compared to 91.2% for the
RPR card test. The Capture-S and RPR card tests produced essentially
equivalent specificities of 99.2% and 99.3%, respectively, for this sample
population. For five test sites, the Capture-S and RPR card test
demonstrated a 98.3% agreement (10,085 of 10,264) of test results. These
evaluations indicate that the Capture-S compares favorably to the RPR card
test in assay sensitivity and specificity, with the added benefits of ease
of use, accommodation of high-volume testing, and potential for automation.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Capture-S, a nontreponemal solid-phase erythrocyte adherence assay for serological detection of syphilis
Immucor, Inc., Norcross, Georgia 30071, USA.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|